EHSI
Elite Health Systems Inc.1.3100
-0.1400-9.66%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
28.74MP/E (TTM)
-Basic EPS (TTM)
-0.14Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Elite Health Systems posted a Q3 net loss of $1.2M, up from $0.3M a year ago, driven by startup costs for its Medicare Advantage plans and non-cash officer compensation; nine-month loss hit $2.0M versus $1.0M prior year as SG&A jumped 57% y/y to $2.0M. No revenue yet, but cash holds at $4.0M after equity raises totaling ~$7.7M YTD, funding software development ($1.0M capitalized) and Elite Health ramp-up. Closed PSS acquisition November 1, 2025 via 3.2M-share exchange. Secured Knox-Keene license May 2025 and CMS conditional approval June 2025 for CY2026. Losses match operating losses. Cash burn hurts.
8-K
Stockholders approve PSS acquisition
Elite Health Systems stockholders overwhelmingly approved electing five directors, doubling authorized common shares to 50M, adopting the 2025 Equity Incentive Plan for 4.5M shares, and acquiring Physician Support Systems via 3.158M share issuance at the September 26, 2025 special meeting. All proposals passed handily with quorums met. Ratified auditors too. Deal expands capabilities.
8-K
Acquires PSS for 3.2M shares
Elite Health Systems entered a Share Exchange Agreement on September 26, 2025, to acquire 100% of Physician Support Systems from its stockholders—including CEO Dr. Prasad Jeereddi (46% owner) and his daughter Dr. Praveena (44%)—for 3,158,000 common shares. The deal awaits stockholder approval and a charter amendment to boost authorized shares. Closing hinges on standard conditions. Related-party ties raise governance flags.
8-K
Secures CMS Medicare contract
10-Q
Q2 FY2025 results
Elite Health Systems posted Q2 net loss of $441,000, up 1% y/y from $435,000 yet improved per share to $(0.02) from $(0.03) thanks to higher shares outstanding. SG&A edged 2% higher y/y to $445,000 on Elite Health startup costs, while H1 loss widened to $865,000 from $747,000 despite 4% lower expenses. Cash dipped to $3.1M from $4.0M year-start after $767,000 software capitalization and $631,000 operating use; equity financings added $474,000. Knox-Keene licensed in May 2025, CMS conditionally approved CY2026 Medicare Advantage. Cash burn continues. Relinquished CBOP stake in June 2025.
AGL
agilon health, inc.
0.67+0.01
ASTH
Astrana Health Inc.
22.31+0.01
CYH
Community Health Systems, Inc.
3.25+0.03
EHAB
Enhabit, Inc.
9.61-0.08
EHC
Encompass Health Corporation
108.01+0.42
FCHS
First Choice Healthcare Solutio
0.01+0.00
HCA
HCA Healthcare, Inc.
469.79-7.19
HWAIF
HealWELL AI Inc.
0.64+0.00
NEUE
NeueHealth, Inc.
6.75+0.00
PIII
P3 Health Partners Inc.
4.59-0.36